Clinical impact and relevance of antibiotic resistance

被引:139
作者
French, GL [1 ]
机构
[1] St Thomas Hosp, Univ London Kings Coll, Dept Infect Dis, London SE1 7EH, England
关键词
antimicrobial resistance; treatment; treatment outcomes; healthcare costs;
D O I
10.1016/j.addr.2005.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increasing antimicrobial resistance and multiple resistance have resulted in increasing difficulties in the treatment of bacterial infections. Resistance leads to inappropriate empirical therapy, delay in starting effective treatment, and the use of less effective, more toxic, and more expensive drugs. Although studies are not always consistent, antimicrobial resistance in the infecting organisms is associated with treatment failure, prolonged or additional hospitalization, increased costs of care, and increased mortality. Additional costs and lost bed days are incurred by the need to control the spread of antimicrobial-resistant organisms within hospitals. All this has significant direct impact on patients and their families and also secondary effects on the cost effectiveness of healthcare delivery. There is an urgent need to control antimicrobial resistance by improved antibiotic usage and reduction of hospital cross-infection. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1514 / 1527
页数:14
相关论文
共 92 条
[51]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes [J].
Lautenbach, E ;
Patel, JB ;
Bilker, WB ;
Edelstein, PH ;
Fishman, NO .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1162-1171
[52]   Resistance to glycopeptides in enterococci [J].
Leclercq, R ;
Courvalin, P .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :545-556
[53]  
Leibovici L, 1998, J INTERN MED, V244, P379
[54]   Rarity of transferable beta-lactamase production by Klebsiella species [J].
Leung, M ;
Shannon, K ;
French, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (06) :737-745
[55]   Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E-faecium [J].
Linden, PK ;
Pasculle, AW ;
Manez, R ;
Kramer, DJ ;
Fung, JJ ;
Pinna, AD ;
Kusne, S .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (04) :663-670
[56]   Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods [J].
Liu, C ;
Chambers, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3040-3045
[57]   Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome [J].
Luna, CM ;
Blanzaco, D ;
Niederman, MS ;
Matarucco, W ;
Baredes, NC ;
Desmery, P ;
Palizas, F ;
Menga, G ;
Rios, F ;
Apezteguia, C .
CRITICAL CARE MEDICINE, 2003, 31 (03) :676-682
[58]   A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure [J].
Macrae, MB ;
Shannon, KP ;
Rayner, DM ;
Kaiser, AM ;
Hoffman, PN ;
French, GL .
JOURNAL OF HOSPITAL INFECTION, 2001, 49 (03) :183-192
[59]   Glycopeptide tolerance in Staphylococcus aureus [J].
May, J ;
Shannon, K ;
King, A ;
French, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :189-197
[60]  
MCGOWAN JE, 2001, EMERG INFECT DIS, V7, P292